Clinical trials recruiting for Hereditary Breast and Ovarian Cancer
4
Recruiting trials
5
US states with sites
2
Countries
50%
Accept healthy volunteers
Phase breakdown
Not applicable 4
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| District of Columbia | 1 |
| Kansas | 1 |
| Missouri | 1 |
| Tennessee | 1 |
| Virginia | 1 |
Top cities
Hays, Kansas 1Kansas City, Kansas 1Kansas City, Missouri 1Lee's Summit, Missouri 1Memphis, Tennessee 1Overland Park, Kansas 1Richmond, Virginia 1Salina, Kansas 1Washington D.C., District of Columbia 1Westwood, Kansas 1
Self-screener
Recruiting trials
- CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
- Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
- Familial Investigations of Childhood Cancer Predisposition
- Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Related conditions
Trials recruiting for Hereditary Breast and Ovarian Cancer often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Lynch Syndrome 28Colorectal cancer 1359Von Hippel-Lindau Disease 6Tuberous Sclerosis 10Rhabdomyosarcoma 4Pheochromocytoma/Paraganglioma 3Pancreatic cancer 870Non Hodgkin Lymphoma 11Neuroblastoma 6
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Hereditary Breast and Ovarian Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.